- Home
- NXGL vs BMRA Comparison
NXGL vs BMRA Comparison
Compare NXGL & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXGL | BMRA |
|---|---|---|
| Founded | 1997 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9M | 5.0M |
| IPO Year | 2019 | 1995 |
Fundamental Metrics
Financial Performance| Metric | NXGL | BMRA |
|---|---|---|
| Price | $0.32 | $2.34 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $2.00 | N/A |
| AVG Volume (30 Days) | ★ 562.1K | 168.1K |
| Earning Date | 05-11-2026 | 04-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 24.00 | ★ 39.81 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $11,421,000.00 | $4,453,000.00 |
| Revenue This Year | $50.77 | N/A |
| Revenue Next Year | $46.15 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 31.46 | N/A |
| 52 Week Low | $0.30 | $1.45 |
| 52 Week High | $2.89 | $3.21 |
Technical Indicators
Market Signals| Indicator | NXGL | BMRA |
|---|---|---|
| Relative Strength Index (RSI) | 41.53 | 75.13 |
| Support Level | $0.32 | $2.04 |
| Resistance Level | $0.61 | $2.29 |
| Average True Range (ATR) | 0.05 | 0.15 |
| MACD | -0.00 | 0.07 |
| Stochastic Oscillator | 25.14 | 87.65 |
Price Performance
Historical ComparisonAbout NXGL NexGel Inc
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. The Company manages its operations as a single operating and reportable segment, which focus on the development, manufacture, marketing, and sale of diagnostic products. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.